Robert Scott McDowell Insider Trading
Get free email notifications about insider trading for Robert Scott McDowell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert Scott McDowell. Robert Scott McDowell is a Vice President, Research in SUNESIS PHARMACEUTICALS INC ($SNSS) and a Chief Scientific Officer in MyoKardia Inc ($MYOK) and a See Remarks in MyoKardia Inc ($MYOK) and a Senior VP, Drug Discovery in MyoKardia Inc ($MYOK).
Address: 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO 94080 CA
Companies in which Robert Scott McDowell is an Insider
MyoKardia, Inc.
Trading Symbol: MYOKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Scott McDowell: Chief Scientific Officer, See Remarks, Senior VP, Drug Discovery
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 19 2020
$MYOK Market Capitalization: $375.56M
$MYOK Previous Close: $12.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viracta Therapeutics, Inc.
Trading Symbol: SNSSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert Scott McDowell: Vice President, Research
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 14 2007
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Robert Scott McDowell
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 19 2020 | MYOK | MyoKardia, Inc. | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | D | 70.40 | 38,818 | 2,732,787 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | D | 40.11 | 57,400 | 2,302,314 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | D | 52.00 | 46,000 | 2,392,000 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | D | 13.90 | 20,000 | 278,000 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | D | 12.25 | 79,850 | 978,163 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | D | 9.08 | 27,211 | 247,076 | 0 | |
Nov 19 2020 | MYOK | MyoKardia, Inc. | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | D | 1.51 | 36,735 | 55,352 | 0 |